We are live on ! Find out more
HL

Harding Loevner Portfolio holdings

AUM $10.6B
1-Year Est. Return 19.39%
This Fund
S&P 500
This Quarter Est. Return
+21.57%
1 Year Est. Return
+19.39%
3 Year Est. Return
+79.14%
5 Year Est. Return
+100.61%
10 Year Est. Return
+428.16%
AUM
$24.2B
AUM Growth
-$3.55B
Cap. Flow
-$7.17B
Cap. Flow %
-29.67%
Top 10 Hldgs %
38.91%
Holding
185
New
7
Increased
34
Reduced
57
Closed
38
Avg Time Held
13.8 quarters
Top 10 Avg Time Held
7.9 quarters
Top 20 Avg Time Held
9.4 quarters

Top Buys

Rank Stock Value
1
BHP icon
BHP
BHP
+$267M
2
EW icon
Edwards Lifesciences
EW
+$199M
3
ISRG icon
Intuitive Surgical
ISRG
+$198M
4
EDU icon
New Oriental
EDU
+$90.8M
5
AMZN icon
Amazon
AMZN
+$63.5M

Sector Composition

Rank Sector Weight
1 Financials 26.48%
2 Technology 25.27%
3 Communication Services 10.11%
4 Consumer Discretionary 9.99%
5 Healthcare 8.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
MTD icon
126
Mettler-Toledo International
MTD
$31.1B
$22K ﹤0.01%
19
– –
2017 Q2
14 quarters
PLNT icon
127
Planet Fitness
PLNT
$3.62B
$21K ﹤0.01%
266
– –
2020 Q1
3 quarters
BKNG icon
128
Booking.com
BKNG
$120B
$20K ﹤0.01%
225
+50
+29% +$3.86K
2015 Q2
22 quarters
ABMD
129
DELISTED
Abiomed Inc
ABMD
$20K ﹤0.01%
63
– –
2020 Q2
2 quarters
APH icon
130
Amphenol
APH
$215B
$19K ﹤0.01%
1,152
– –
2017 Q2
14 quarters
TXN icon
131
Texas Instruments
TXN
$259B
$19K ﹤0.01%
115
– –
2020 Q1
3 quarters
AME icon
132
Ametek
AME
$57B
$18K ﹤0.01%
147
-623
-81% -$70.2K
2020 Q2
2 quarters
RMD icon
133
ResMed
RMD
$32.4B
$17K ﹤0.01%
81
– –
2019 Q1
7 quarters
V icon
134
Visa
V
$724B
$17K ﹤0.01%
76
– –
2020 Q3
1 quarter
EXPO icon
135
Exponent
EXPO
$3.32B
$16K ﹤0.01%
175
– –
2018 Q4
8 quarters
RGEN icon
136
Repligen
RGEN
$11B
$15K ﹤0.01%
80
– –
2019 Q3
5 quarters
CHL
137
DELISTED
China Mobile Limited
CHL
$15K ﹤0.01%
541
-9,645,612
-100% -$298M
2015 Q1
23 quarters
LMAT icon
138
LeMaitre Vascular
LMAT
$1.85B
$13K ﹤0.01%
317
– –
2019 Q4
4 quarters
REGN icon
139
Regeneron Pharmaceuticals
REGN
$76.9B
$13K ﹤0.01%
26
-2
-7% -$1.08K
2016 Q2
18 quarters
FIVE icon
140
Five Below
FIVE
$11.8B
$8K ﹤0.01%
+44
New +$6.52K
2020 Q4
0 quarters
WAT icon
141
Waters Corp
WAT
$42.6B
$8K ﹤0.01%
34
-32
-48% -$7.25K
2014 Q2
26 quarters
CABO icon
142
Cable One
CABO
$63.2M
$7K ﹤0.01%
3
– –
2019 Q2
6 quarters
ELAN icon
143
Elanco Animal Health
ELAN
$11.5B
$5K ﹤0.01%
169
– –
2019 Q2
6 quarters
HP icon
144
Helmerich & Payne
HP
$3.99B
$5K ﹤0.01%
227
– –
2017 Q2
14 quarters
GRFS icon
145
Grifois
GRFS
$5.08B
$2K ﹤0.01%
91
-8,911
-99% -$165K
2014 Q2
26 quarters
SLB icon
146
SLB Ltd
SLB
$72.6B
$2K ﹤0.01%
107
– –
2013 Q2
30 quarters
SSL icon
147
Sasol
SSL
$9.69B
$1K ﹤0.01%
80
– –
2013 Q2
30 quarters
ALC icon
148
Alcon
ALC
$31B
– –
-1,751,372
Closed -$99.7M –
KOF icon
149
Coca-Cola Femsa
KOF
$23.1B
– –
-4,577
Closed -$186K –
MMM icon
150
3M
MMM
$82.5B
– –
-680,613
Closed -$91.2M –

Similar funds

Harding Loevner's Q4 2020 Portfolio in Review

As of Q4 2020, Harding Loevner held 185 positions worth $24.2B, down 13% from $27.7B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Harding Loevner withdrew a net $7.17B in Q4 2020, closing 38 positions and reducing 57 holdings. Its most notable exit was INFINEON TECH AG ADS(REP1 ORD), an estimated $374M position sold in full.

By sector, the portfolio is most concentrated in Financials at 26% of assets, up from 17% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Harding Loevner opened a new position in BHP worth $311M.

  • Harding Loevner's largest Q4 2020 buy was BHP: 5,333,251 shares worth $311M.
  • Harding Loevner added most to Edwards Lifesciences in Q4 2020, an estimated $199M increase.
  • Harding Loevner's biggest Q4 2020 reduction was Roper Technologies, cutting an estimated $299M.
  • Harding Loevner fully exited INFINEON TECH AG ADS(REP1 ORD) in Q4 2020, selling an estimated $374M.
  • Harding Loevner's ten largest holdings make up 39% of its $24.2B portfolio in Q4 2020.
  • Harding Loevner opened 7 new positions and closed 38 in Q4 2020.
  • Harding Loevner's portfolio value fell 13% quarter-over-quarter to $24.2B.

Based on Harding Loevner's 13F filing for Q4 2020, filed 16 Feb 2021.